Special Issue "Cancer Biomarker Research and Personalized Medicine 2.0”

In 2022, there was an estimated incidence of 20 million cancer cases and 9.7 million deaths from cancer worldwide. By the year 2050, the rates of cancer incidence and death are projected to increase to 35.3 and 18.5 million, respectively [1]. It is thought that cancer mortality rates will surpass cardiovascular disease mortality rates in the near future [2]. While improvements have been made in the diagnosis and treatment of various cancer types, it is evident from these statistics that further breakthrough advancements are necessary to decrease the significant social and economic impact this disease has on the population